Law Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breache...
20 Luglio 2012 - 1:36AM
Business Wire
Law Offices of Howard G. Smith announces that it is
investigating potential claims against the Board of Directors of
Human Genome Sciences Inc. (“Human Genome” or the “Company”)
(NASDAQ: HGSI) related to the proposed acquisition of the Company
by GlaxoSmithKline PLC. The transaction is valued at approximately
$3.6 billion or $14.25 per share.
This investigation concerns whether the Board of Directors of
Human Genome breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into the proposed transaction, and whether the Company has
disclosed all material information to shareholders about the
transaction. The Company has seen substantial recent growth.
Further, at least one analyst has set a target price for the
Company’s stock at $23.00.
If you are a shareholder of Human Genome, if you have
information or would like to learn more about our investigation, or
if you wish to discuss these matters or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire,
of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll
Free at (888) 638-4847, or by email to
howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Human Genome Sciences, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Law Offices of Howard G. Smith Articoli Notizie